Over the past decades, engineers have introduced numerous technologies that rely on light and its underlying characteristics.

Temozolomide combined with radiation as first-line treatment in primary glioblastoma multiforme: Phase I/II-study No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--HyperLight, creator of the TFLN Chiplet™ platform, today announced the launch of its groundbreaking 110 GHz Low Vπ Intensity Modulator, featuring industry-standard ...